Photo taken from ESMO/X
May 15, 2024, 13:47
Interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter – ESMO
The European Society for Medical Oncology (ESMO) shared on X:
“While novel agents continue to enrich the therapeutic armamentarium in mCRC, patients expect not only prolonged survival, but also higher QoL.
Read the interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter.”
Source: ESMO/X